Scientists have known for several years that microplastics can pass into the bloodstream, lodge themselves in vital organs, and potentially lead to physiological disturbances, but the mechanistic details were sparse. Researchers often relied on analysis of tissues after exposure, or on markers in blood and urine, to guess where microplastics might end up. Adding to the confusion, not all microplastics are created equal. They vary in size, chemical composition, surface structure, and weathering status, all of which might influence how they traverse biological barriers such as the intestinal lining or the blood–brain barrier. This new study, led by biomedical researcher Haipeng Huang and colleagues at Peking University, marks a substantial leap forward because it used a novel imaging approach—miniature two-photon microscopy—to peer deep into the biological processes unfolding in living mice. Rather than waiting to dissect tissues post-mortem, scientists could watch in real time as fluorescently labeled plastic particles navigated through blood vessels, were taken up by immune cells, and then, in certain grim scenarios, created blockages within narrow capillaries in the brain’s cortex. This method, akin to peering through a surgically implanted window in the skull, provided unprecedented clarity about where exactly the microplastics go and how they might cause trouble when they arrive.

As the researchers fed the mice water containing a suspension of polystyrene spheres, they observed that, within hours, some bright specks of fluorescence appeared within specific immune cells, such as neutrophils and phagocytes. Intriguingly, these plastic-laden cells seemed to get caught in the cramped curves of tiny blood vessels. In effect, the blood vessels themselves became potential choke points. Over time, more plastic-stuffed cells would pile up, much like the multi-car collisions that can clog a highway after a single vehicle slams on the brakes. Some blockages quickly resolved, but in other cases, the clumps remained firmly lodged for many days or even weeks, cutting off local blood flow. For the mice in question, these obstructions correlated with measurable reductions in cerebral blood circulation and a decrease in mobility—a subtle sign of potential neurological or systemic compromise. The authors likened these accumulations to blood clots in their overall effect, although instead of aggregated platelets, the plug consisted mainly of white blood cells loaded with tiny plastic fragments. Importantly, the phenomenon was less pronounced when the plastic spheres were significantly smaller; that is, the obstructions seemed to be more prominent with relatively larger “micro”-sized fragments compared to even tinier “nano”-scaled plastic. This hints that size is not just a trivial detail but a central parameter in how microplastics inflict damage at the vascular level.

These findings bolster other research hinting that microplastics can reach deep into the body. In the past few years, scientists have identified microplastics in human lungs, livers, kidneys, and even in the placentas of pregnant women. A study referenced by the authors suggested that plastic deposits in the aorta might be correlated with elevated risk of cardiovascular disease, including stroke and heart attack. The mechanistic link remains tenuous, and it’s still unknown whether the microplastics actively cause pathology or merely accumulate as innocent bystanders that reflect high plastic exposure. Nevertheless, the correlation is concerning. The scenario in the brain, as documented by Huang’s team, points toward a plausible mechanism by which these particles might impair organ function: mechanical blockages that hamper blood flow. Blood-starved brain tissue can provoke a range of neurological problems, from mild confusion to severe deficits, depending on the extent and location of the ischemia. While it’s premature to generalize about how these findings translate to human biology, any evidence of vascular obstruction is enough to prompt calls for further investigation, particularly given the ubiquity of microplastics in day-to-day life.

The ramifications of these obstructions go beyond the immediate, localized consequences. When neutrophils and phagocytes ingest microplastics, they are presumably responding to them as foreign particles. This immune response has its own potential set of consequences, such as inflammation, release of reactive oxygen species, and perturbations in normal immune cell trafficking. The fact that these plastic-laden cells could accumulate in the microvasculature suggests that local inflammation might be heightened in these choke points. Chronic inflammation in the brain has been tied to degenerative processes, including exacerbation of conditions like Alzheimer’s disease and Parkinson’s disease, although no direct link has been established with microplastics thus far. Moreover, each of these conditions is known to involve, in part, compromised microvasculature or immune dysregulation. Therefore, even a modest accumulation of microparticles in the brain’s blood vessels, if persistent or repeated, might shape the overall risk profile for a variety of neurological disorders. Although these ideas remain speculative, the new study’s demonstration that microplastics can cause measurable obstructions in real time does shift the conversation from mere presence of microplastics in the body to deeper questions about function and pathology.

The question of how exactly these plastic particles gain entrance to the bloodstream, and then sometimes to the brain, has stimulated intense interest. People routinely consume microplastics through food, whether by ingesting small plastic fragments shed by containers or from seafood that has accumulated plastics in its tissues. Meanwhile, plastic fibers in the air may be inhaled, lodging in the lungs or sneaking through the alveoli into circulation. Hospital settings can also be a source of plastic exposure, because medical devices—from IV bags and tubes to catheters—have the potential to shed microscopic plastic shards, especially when used repeatedly or at high pressures. Once in the bloodstream, these particles presumably travel throughout the body, encountering filtration systems such as the liver and kidneys. Some fraction might be excreted, but others may settle in tissues, depending on the structure of blood vessels and any immune cell activity that helps them cross biological barriers. Nanoplastics (measuring well below one micrometer) might even interact differently than microplastics, and the study confirms that size variations can lead to different rates of accumulation. This heterogeneous landscape complicates efforts to define “safe” exposure levels or universal predictions about where in the body these plastics might end up.

Of course, mice are not humans, and it remains unknown whether these blockages are a frequent occurrence in the human population or whether our bodies are more adept at clearing out these plastic-laden cells over longer timescales. Still, the revelation that microplastic obstructions can even occur at all—fully visible in the blood vessels of a living mammalian brain—is deeply unsettling. Adding to the significance, the authors of this new study have observed similar phenomena in unpublished work regarding the heart and liver. While it’s possible that these events are rare under typical exposure levels, the proliferation of plastics in our environment, combined with the massive volume of plastic waste not being adequately recycled or contained, suggests that the concentration of microplastics in our air, food, and water could continue to rise. With every increment of plastic that accumulates in our everyday environment, the likelihood of inhaling or ingesting these minute particles grows, and so, too, does the probability of them ending up in sensitive tissues such as the brain.

One especially provocative element of the new research is the detection of microplastics within specific immune cells. Neutrophils are generally among the first responders to infections or foreign bodies, rushing to sites of inflammation. Phagocytes, which include macrophages, are well known for their capacity to engulf foreign particles. That the plastic-laden immune cells then become clogged in the brain’s microvasculature raises a cluster of intriguing immunological questions. Do these immune cells attempt to degrade or break down the plastics? Is the presence of plastic inside immune cells a stress signal that triggers broader immunological cascades? Could certain chemical coatings or additives in the plastics—like flame retardants or plasticizers—leach out and cause additional harm? The authors have not yet unraveled such nuances, but the presence of plastic-laden immune cells suggests that the body recognizes microplastics as alien objects, at least to a degree, and that the normal processes meant to handle unwelcome intruders might inadvertently lead to further complications, such as the “car crash” blockages witnessed in the vessels.

Another dimension is the potential role of “weathered” microplastics, which are shaped by the environment—be it ultraviolet radiation from the sun, chemical exposures in water, or mechanical abrasions—that can alter their surface properties. The new study used fluorescent polystyrene spheres, presumably smooth and uniform, as the test microplastic. However, real-world plastics rarely remain so pristine. In a separate piece of unpublished work, or in complementary research conducted by other teams, scientists discovered that weathered plastics, replete with pits, cracks, or irregular shapes, might be more easily bound by proteins or recognized by immune cells, thus complicating the story further. They might also leach out more chemical additives, or even pick up pollutants along their journey. If the real microplastics in everyday life are more chemically reactive, or more abrasive, than the polystyrene used in the study, they might induce even stronger immune responses or be more readily transported into tissues.

Despite these ominous hints, it’s important to note that the new research still leaves many unanswered questions about direct health ramifications. The partial reduction in blood flow observed in the mice was associated with decreased mobility, which could reflect either mild ischemic events or other subtler neurological effects. However, the results did not suggest any extreme outcomes like immediate strokes or fatal events—at least not under the controlled exposure conditions tested. Whether these blockages could contribute to neurodegenerative processes, or whether repeated exposure leads to cumulative harm, remains to be determined. Larger-scale and longer-term studies might be required, potentially spanning months or years, to assess how chronic microplastic ingestion might contribute to overall health deficits. The authors also emphasize that their findings do not prove that human brains are routinely besieged by plastic-laden immune cells, merely that the phenomenon is possible in a living mammal under certain exposure scenarios.

Researchers in environmental health are already expressing keen interest in the methodology utilized by Huang’s team, particularly the way they used a surgically implanted “window” in the mouse skull to visualize the bloodstream using two-photon microscopy. Traditionally, microplastic research has relied on dissecting tissues to find evidence of plastic, or using indirect biomarkers. But real-time imaging of living tissue allows scientists to track how quickly microplastics appear after ingestion or injection, see which cells pick them up, document exactly where they end up, and measure how long they persist. This capability could revolutionize our understanding of microplastics, making it possible to study how different shapes, sizes, or surface chemistries affect their distribution. Moreover, it could be applied to different tissues as well—heart, liver, kidneys, or even lymphatic systems—to produce a comprehensive map of microplastic transit throughout the body. Such knowledge is a crucial stepping stone if legislators and public-health agencies are to craft science-based guidelines for acceptable plastic exposure limits, or if they wish to prioritize the mitigation of certain plastic types over others.

A pressing challenge is bridging the gap between these laboratory findings and the real world. Microplastic contamination is a global crisis. Plastic litter in waterways breaks into particles that can be swallowed by fish, shellfish, or birds, and eventually consumed by humans. Microscopic fibers from clothing or household dust swirl in the air, silently inhaled day in and day out. With advanced chemical detection techniques, microplastics have been found in virtually every habitat, including farmland soils, polar sea ice, and even remote mountaintops. The quantity of plastic production worldwide has soared into the hundreds of millions of tonnes annually, with projections suggesting more plastic in the ocean than fish by weight within a few decades if current trends persist. As scientists piece together the toxicological picture of microplastics in organs such as the brain, the impetus for more robust pollution control, recycling, and alternative packaging solutions grows more urgent. If we discover that microplastics are not merely inert particulates but can actively disrupt or damage bodily systems, the environmental stakes intensify further.

In the broader picture of public health, the new revelations also resonate with concerns about other synthetic materials and environmental contaminants we encounter. For instance, particulate matter from automobile exhaust has likewise been implicated in numerous cardiovascular and neurological problems. Such parallels raise the possibility that tiny plastic fragments might combine with other pollutants to produce cumulative or synergistic effects. A person living in a high-traffic urban zone might be ingesting or inhaling not just microplastics but also metal nanoparticles, soot, and a cocktail of airborne chemicals. Untangling the individual and collective contributions to disease processes is a formidable undertaking. The mice in Huang’s study were otherwise healthy, well-controlled test subjects living in a sanitized laboratory, fed with a carefully measured dose of polystyrene. Real-world conditions, by contrast, are more chaotic and varied.

Looking forward, the journey does not end with mice. Researchers will need to investigate whether there are plausible pathways for these vascular blockages to occur in humans and, if so, whether the frequency and duration of such events might be correlated with neurological symptoms or diseases. Autopsy studies, similar to the ones that have found microplastics in deceased humans’ cardiovascular tissues, might help confirm the presence of plastic obstructions in brain vasculature. Additionally, population-scale research could compare microplastic burdens in tissues with clinical outcomes, shedding light on whether individuals with higher exposure levels have an elevated risk of neurological impairments over time. In parallel, scientists may refine the imaging techniques, perhaps using label-free approaches or advanced scanning methods, to identify microplastics in living organisms without requiring fluorescent tagging. All these efforts could pave the way for discovering interventions or preventive measures—ranging from refining water-filtration technologies to reducing or banning certain kinds of plastics that tend to fragment into highly problematic sizes.

Even though the new report raises numerous questions and concerns, it also highlights the resilience and complexity of biological systems. The fact that some obstructions cleared spontaneously suggests that the body has a capacity, at least under certain conditions, to dislodge or dissolve the blockages. Through normal immune function or perhaps specialized clearance mechanisms, the body might be able to mitigate the harm posed by occasional microplastic exposures. The critical unknown is whether these natural processes break down under higher loads or chronic exposure, leading to scenarios where plastic-laden immune cells persist and do real damage. For now, the wise course of action involves continuing to investigate, while also renewing commitments to curb unnecessary plastic use and pollution. Although complete elimination of plastic from modern life is impractical, steps can be taken to limit single-use plastics, improve recycling rates, and promote biodegradable or less harmful alternatives.

Should the worst fears about microplastic-induced vascular obstructions be validated by subsequent research, the implications might be wide-ranging. It could transform how we regulate plastic in medical devices, packaging, and consumer products. Public pressure for robust microplastic monitoring in water and air systems may well intensify, following the logic that preventing microplastics from proliferating in the environment is easier than removing them once widespread contamination has occurred. Already, some governments and environmental groups have begun to push for microplastic pollution standards, but those efforts are hobbled by incomplete data on the health impacts and uncertain detection techniques. This new demonstration of real-time microplastic blockages in the brains of living mammals stands as a stark reminder that these minuscule fragments, once considered too small to worry about, may trigger outsized physiological disruptions.

There is a paradox in modern life: we rely on plastic for convenience and innovation—medical supplies, protective equipment, electronics, and more—yet we’re rapidly coming to realize the hidden costs of these same materials when they degrade into tiny bits that we cannot see or control. If microplastics can, under certain circumstances, gather inside blood vessels in the brain and mimic the behavior of clots, the possibility that we could face subtle yet broad-ranging public health impacts becomes harder to dismiss. Scientists like Huang and his colleagues, armed with powerful imaging tools, are leading the way in unraveling the hidden journey of plastic inside living organisms. Each new technique or data set adds weight to the notion that microplastics belong on the list of modern pollutants deserving serious scrutiny. As we deepen our knowledge, we might discover that our best defense against plastic infiltration is not a single new technology or medical test, but a fundamental overhaul of how we produce, use, and dispose of plastic in the first place. The story of microplastics is, in essence, the story of our modern age—one of convenience, consumption, and environmental oversight. With each fresh insight into their effects on living systems, we inch closer to recognizing that the hazards they pose may be more direct and immediate than previously believed. Ultimately, the fate of microplastics in the brain might become a potent symbol of the deeper tensions between technological progress and ecological well-being, urging us to re-examine our relationship with plastic and our collective responsibility for the health of both the planet and ourselves.

Subject of Research: Obstruction of blood flow in the brain by microplastics in mice
Article Title : Microplastics block blood flow in the brain, mouse study reveals
News Publication Date : 23 January 2025
Article Doi References : https://doi.org/10.1038/d41586-025-00178-0
Image Credits : Scienmag
Keywords : Microplastics, Brain blood flow, Immune cells, Mouse study, Two-photon microscopy, Environmental pollution, Neurovascular obstruction, Public health

Entorhinal grid cells exhibit low-dimensional manifold activity, typically visualized in two-dimensional phase space repeated periodically to tile an environment. The idea that these neural states could provide a clothesline-like scaffold for storing arbitrary information means that the grid pattern is not merely for location coding in real space; instead, the grid’s periodic structure can be harnessed to generate robust fixed points that accommodate an exponentially large set of stable representations. When these stable states become associated with random or user-defined inputs, the system can retrieve them content-addressably. One crucial message is that the large set of stable attractors is the product of relatively fixed or infrequently modified connectivity between the grid cell modules and the hippocampal layer. The circuit as a whole effectively divorces the generation of stable, wide-basin attractors from the content that might be placed upon them. This factorization solves a longstanding puzzle in memory models: the trade-off between a small set of perfect recalls versus a large set of approximate or entirely failed recalls. Here, the number of possible attractor states becomes staggering, and old items remain resilient when new items are added.

The approach also accounts for the hallmark property of hippocampal remapping. Experimentally, once a rodent or other mammal is introduced into a new environment, place cell ensembles drastically shift their firing patterns so that the old environment’s representation does not interfere. In this model, the re-initialization to a new environment corresponds to a distinct chunk of the scaffold’s overall grid-code space. Because the entorhinal grid modules can hold a huge range of phases, each environment can be assigned a unique configuration that does not overlap with prior environments. As a result, the hippocampal states that read out from those grid codes are likewise orthogonal. This eliminates catastrophic interference and permits the same circuit to learn an ongoing stream of new environments or contexts without wiping out older memories. Without further training or sophisticated consolidation steps, the system can store as many environment maps as it has non-overlapping patches of grid-coding states. The structure of place fields emerges, not from the system fine-tuning itself to the environment, but from the preexisting rule that grid modules, once locked to a consistent phase for that environment, drive the hippocampus to produce localized hotspots reminiscent of place cells. The advantage is that no environment-specific shaping is needed; the place fields appear robustly from the scaffold’s universal architecture.

Episodic memory, conceptualized as sequences of events anchored in time or associative transitions, maps naturally onto the same framework. Where the environment-based scenario takes an agent physically from location A to B, the episodic scenario moves the network through a chain of states that can be regarded as “abstract positions” in a conceptual space. If each step of a sequence is triggered by a low-dimensional velocity or shift parameter, the memory of how to get from the last position to the next becomes simpler. Traditional sequence memory models demand that the entire high-dimensional pattern at step t must drive the entire next pattern at step t + 1, which quickly saturates the network’s ability to store more than a handful of sequences. However, if the network’s internal states are pinned to this grid-based scaffold, one only needs to specify a two-dimensional velocity (or similarly compact code) that moves the system from one grid phase to the next. The cost in bits of specifying a velocity is minuscule compared with encoding a full pattern, so the network can store extremely long sequences. Such sequences can be purely abstract: the model does not require actual physical movement. Hence, one gains an enormous episodic capacity, in the sense that the scaffold can preserve correct transitions among thousands of steps, each optionally tethered to external inputs for recall. Observers might think it paradoxical that adding a low-dimensional path-integration mechanism—often described in purely spatial terms—resolves the fundamental limitation of storing extended event sequences. But it becomes obvious once one recognizes that the standard neural networks struggle with the overhead of retrieving entire next states, whereas the grid-based approach has a built-in compression for transitions that is inherited from the path-integration mechanism.

Grid cells in this model preserve their relative phase relationships across the entire circuit’s operation, consistent with recordings that find stable geometric relationships among cells in the same module. The hippocampus, however, can be fully rearranged from environment to environment or from context to context. In a T-maze alternation task, the same physical corridor can lead to divergent hippocampal representations if an abstract context difference triggers a new grid phase initialization. The place-like activity is thus partly under the direct control of grid codes, which, in turn, can be locked to different contextual anchors. Alternatively, if entorhinal input is absent, velocity-driven path integration alone can preserve stable place fields in the short term, though errors eventually accumulate. Conversely, if grid input is silenced but sensory inputs remain, hippocampal place fields remain stable because the extrahippocampal signals can override the absent path integration, effectively turning the scaffolding into a pure heteroassociative recall mode. These manipulations align well with empirical observations in which partial inactivations of entorhinal or hippocampal populations degrade spatial tuning in distinct ways.

Even more intriguing is how these circuit motifs account for the age-old memory trick known as the memory palace. People trying to memorize large amounts of information, like a randomized deck of cards, often imagine walking through a familiar building, placing each item in a specific location. By later mentally retracing that route, they can retrieve each item in sequence. The puzzle is that this extra step—imagining a building or route—seems to add an additional cognitive load, yet it yields spectacular memory improvements. In the scaffold perspective, the memory palace is effectively a well-tuned path in the preestablished grid code. The building or route is vividly known, so the hippocampal–grid circuit reproduces an internal sequence of states with effectively perfect fidelity, even though the detailed recall of that building’s features might be approximate if the system is operating deep in the memory continuum. Nevertheless, each location in the memory palace is reactivated in a stable and consistent way, acting as a new mini-scaffold. The memorized items are heteroassociated onto these well-anchored states, so they do not require the huge overhead that direct storage of an entirely new sequence would entail. The memory capacity is further magnified because one can reuse the route multiple times, or use different palaces. So the method of loci is not just a whimsical technique; it is evidence that the hippocampal–entorhinal system is specifically designed to exploit stable sequences of grid-defined states in memory tasks.

This network also clarifies the difference between memorizing high-fidelity content and simply remembering the gist or correct identity. Traditional networks often produce a memory cliff: once more patterns are stuffed in than the system capacity, everything collapses. Here, the item memory or episodic memory transitions into a continuum domain. The circuit might store thousands of patterns, and retrieval remains accurate in the sense of retrieving the correct item identity, even if the precise details degrade. The stored pattern is pulled, during recall, into the correct “Voronoi cell” of the sensory space, meaning the system identifies the item or route properly, though not every pixel is reproduced. That sets up a continuum between perfect recall for fewer than a certain threshold of items and partial but stable recall for more items. This partial recall is consistent, so if the same cue is given later, the same approximate pattern is recalled, letting the memory palace approach piggyback on that stable if slightly imperfect retrieval. The entire phenomenon is reminiscent of a compressed code or error-correction scheme in data storage, but with the difference that these codes are adapted to neural constraints—bipartite expansions, local excitations, and robust grid subcircuits.

One might ask: how do these hippocampal representations avoid spurious attractors, in which ambiguous partial cues lead to nonsense retrieval? The short answer is that the space of grid states, together with the hippocampal random projection and carefully set return weights, provides guaranteed local basins of attraction around each designated state. The place fields or item codes do not produce spurious stable states because their attractor layout is not determined by the random patterns themselves, but by the prewired structure of the grid modules. This yields large, uniform basins with no spurious minima, establishing that the entire system is an error-correcting memory map. If the partial cue is close enough to the original item in the sense of Hamming or Euclidean distance, it is recovered as intended. If it is too far away, the circuit picks the nearest item in that space. Ties rarely happen, because the random projection from entorhinal or cortical signals has extremely low probability of placing two distinct items near each other in hippocampal space.

Beyond the standard replays and offline consolidation that many hippocampal theories highlight, this model underscores that repeated exposures to some items effectively reinforce the hippocampal-to-sensory links so that memory for those items becomes less reliant on the hippocampus. If the hippocampus were partially lesioned, such items remain well recalled, while newly introduced or rarely repeated items degrade more readily. The model thus dovetails with the classical notion of complementary learning systems, in which repeated experiences ensure that certain memories are transferred or consolidated into more stable cortical representations, requiring less HPC involvement in the long run. However, the difference is that here, that consolidation occurs within the HPC–cortex connectivity itself, rather than a separate inter-area consolidation. The HPC–grid circuit remains a generative scaffolding device for the original memory.

To test or refute the scaffolding theory, empirical neuroscientists could design experiments investigating whether grid cell activity exhibits stable, repeating states in purely abstract recall tasks that have nothing to do with navigation. If grid cells shift in repeated patterns that look analogous to movement across a two-dimensional torus, that would confirm the notion that the HPC–EC synergy harnesses consistent low-dimensional transitions for memory sequences. Another test is to record from HPC and entorhinal cells during memory palace use in a well-trained participant or model organism. The theory predicts that stable HPC–EC states appear in sequences corresponding to the path through the imaginary environment, even if the real environment is entirely different or the subject remains immobile. This sort of “covert path integration” is quite reminiscent of mental navigation phenomena reported in fMRI studies. Additional tests could examine partial HPC or entorhinal inactivation to see whether it abolishes stable memory of certain episodes, or if HPC inactivation disrupts grid cells’ pattern stability when no external reference cues are visible.

In sum, hippocampal circuits unify the tasks of building robust spatial representations, forming item or sequence memories in a continuum fashion, and enabling the method of loci to achieve spectacular feats of recall. The key lies in factorizing the problem: the HPC–grid loop sets up stable states that are easy to clean up from noise and have no spurious minima, while the HPC–cortex (or HPC–non-grid entorhinal) connections store which item is associated with which stable state. The HPC–grid loop also uses a low-dimensional velocity or shift operator to chain states into sequences, allowing indefinite expansions in sequence length. By harnessing a prewired scaffolding code, the circuit masters the dual demands of rapid memorization and enormous capacity. That the HPC–EC region invests in grid cells for purely spatial coding is only half the story. The same grid-based structure is presumably also used in purely non-spatial tasks, from replaying childhood memories to visualizing purely imaginary scenarios. Far from being an accidental side effect, the grid code may be a universal engine for memory, supporting not only navigation but also the infinite journeys of the mind.

Subject of Research: Neural Circuits for Memory and Navigation
Article Title : Episodic and Associative Memory from Spatial Scaffolds in the Hippocampus
News Publication Date : 15 January 2025
Article Doi References : https://doi.org/10.1038/s41586-025-06020-z
Image Credits : Scienmag
Keywords : hippocampus, entorhinal cortex, episodic memory, spatial scaffolding, grid cells, vector transitions, content-addressable recall, memory palace, path integration, attractor dynamics

Social connections are fundamental to human survival and well-being, yet modern societies face an increasing prevalence of social isolation and loneliness. These two constructs, while related, represent distinct facets of social disconnection: the former being an objective state of limited social interactions and the latter a subjective feeling of being alone. Both have been empirically linked to increased morbidity and mortality, with effects comparable to traditional risk factors like smoking and obesity. However, the biological mechanisms mediating these associations have remained elusive – until now.

This comprehensive study utilized high-throughput plasma proteomics to explore the proteomic profiles associated with social isolation and loneliness. The findings illuminate shared and distinct molecular pathways, particularly those involving inflammation, antiviral responses, and complement systems, that underlie the health impacts of social disconnection. Furthermore, the study extends beyond correlation, employing Mendelian randomization (MR) to infer causality, thereby identifying five key proteins—GFRA1, ADM, FABP4, TNFRSF10A, and ASGR1—as central mediators in the relationship between loneliness and adverse health outcomes.

Proteins, as the functional products of gene expression, are critical to understanding disease mechanisms and represent prime targets for therapeutic interventions. In this study, 776 proteins were initially associated with social isolation and 519 with loneliness, with 175 and 26 proteins, respectively, maintaining significance after rigorous statistical adjustments. Growth differentiation factor 15 (GDF15), an inflammatory marker, emerged as the most strongly associated protein with social isolation, while proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of cholesterol metabolism, was most significantly linked to loneliness. Importantly, over 50% of these proteins were prospectively linked to major diseases and mortality over a 14-year follow-up.

The interplay between these proteins and health was further dissected using protein-protein interaction (PPI) networks and pathway enrichment analyses. Hub proteins such as interleukin 6 (IL6) and intercellular adhesion molecule-1 (ICAM1) were identified, underscoring the pivotal role of immune and inflammatory pathways in the biological impact of social disconnection. Notably, proteins linked to social isolation exhibited enrichment in complement activation and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathways, while loneliness was associated with metabolic and antiviral processes.

Building on these findings, the study employed MR analysis to infer causal relationships. Loneliness was causally linked to changes in the abundance of five proteins, with ADM and ASGR1 showing strong evidence of colocalization, indicating a shared genetic basis for loneliness and these protein levels. ADM, a protein involved in neuroendocrine stress responses and inflammation, exhibited robust associations with systemic biomarkers such as C-reactive protein (CRP) and brain regions implicated in interoception and emotional processing. These findings highlight ADM’s central role in translating the experience of loneliness into physiological changes that predispose individuals to disease.

The study also explored the mediating role of these proteins in the relationship between loneliness and health outcomes. ADM was identified as a key mediator, explaining up to 16.3% of the excess mortality risk associated with loneliness. The findings suggest that loneliness exerts its health effects not only through behavioral pathways, such as reduced physical activity or unhealthy diets, but also through direct biological mechanisms involving specific proteins and pathways.

To validate these findings, the researchers conducted extensive sensitivity analyses, including stratified analyses by sex, age, and ethnicity, as well as replication in a representative subset of the UK Biobank. The robustness of the results was further supported by cross-validation, colocalization analyses, and mediation modeling. While the study is limited by the observational nature of the data and the inability to measure protein levels in specific tissues, the authors argue that the plasma proteome provides a valuable window into systemic physiological processes.

This research represents a significant leap forward in understanding the biological basis of social relationships and their impact on health. By identifying specific proteins and pathways involved in the effects of social isolation and loneliness, the study opens new avenues for targeted interventions. Potential strategies could include developing drugs that modulate the activity of these proteins, designing biomarkers for early detection of at-risk individuals, or implementing public health policies aimed at reducing social disconnection.

The study underscores the critical importance of social relationships for human health and survival. The proteomic signatures of social isolation and loneliness reveal a complex interplay between biological, psychological, and social factors, offering a comprehensive framework for addressing the health consequences of social disconnection. As societies grapple with the challenges of an increasingly disconnected world, these findings provide a compelling case for prioritizing social relationships as a public health imperative.

Subject of Research: Plasma proteomics and social relationships
Article Title: Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality
News Publication Date: 03 January 2025
Article Doi References: 10.1038/s41562-025-00987-5
Image Credits: Not specified
Keywords: Social isolation, Loneliness, Plasma proteomics, Morbidity, Mortality, Inflammation, Mendelian randomization, Public health, Cardiovascular disease, ADM protein

The recipient of the second genetically modified porcine heart was a 58-year-old man suffering from severe, progressive, inotrope-dependent heart failure caused by ischemic cardiomyopathy. Despite a history of advanced heart failure therapies, the patient’s severe peripheral and central atherosclerotic vascular disease, coupled with a recent gastrointestinal bleed, rendered him ineligible for standard heart transplantation or durable mechanical circulatory support. After thorough evaluation and preparation, the decision to proceed with the experimental xenotransplantation was made, guided by stringent ethical oversight and informed patient consent.

This groundbreaking procedure utilized a porcine heart with ten specific genetic modifications designed to reduce the risk of immune rejection and minimize other complications. Advances in donor screening protocols played a critical role in mitigating the potential risks associated with zoonotic pathogens, such as porcine cytomegalovirus (PCMV), a factor suspected of contributing to complications in the first case. Comprehensive serological and polymerase chain reaction (PCR) testing ensured that the donor animal was free of latent PCMV and other infectious agents. The heart was preserved using the XVIVO Heart Perfusion System, a state-of-the-art technology that maintained organ viability during the transplantation process.

The patient’s preoperative optimization included meticulous fluid management to address cardiorenal syndrome and improve overall health before the transplant. However, the patient experienced a critical ventricular fibrillation event requiring resuscitation hours before surgery. Despite this setback, the transplant team proceeded with confidence, guided by the improved physiological condition of the patient compared to the first xenotransplant recipient.

The transplant surgery itself was a success. Following implantation, the porcine heart demonstrated excellent initial function, with no need for inotropic support and only minor pacing adjustments to achieve optimal heart rates. Postoperative imaging revealed significant resolution of pulmonary edema and pleural effusions, highlighting the functional improvement provided by the xenograft. However, the patient faced early challenges, including perioperative acute kidney injury and persistent vasoplegia, which were managed with continuous renal replacement therapy and vasopressor support.

The patient’s post-transplant journey was marked by a series of complex immunological and physiological events. Early echocardiographic assessments showed preserved left ventricular systolic function and robust global longitudinal strain, indicative of healthy graft performance. Yet, the emergence of diastolic dysfunction, biventricular wall thickening, and declining systolic function signaled the onset of graft failure. A comprehensive right heart catheterization confirmed restrictive hemodynamics, while biopsies revealed signs of antibody-mediated rejection (AMR), characterized by endothelial injury, complement deposition, and interstitial edema.

Efforts to counter AMR included therapeutic plasma exchange, complement inhibition with eculizumab, and adjustments to immunosuppressive regimens. Despite these interventions, the patient’s condition deteriorated, necessitating extracorporeal membranous oxygenation (ECMO) by postoperative day 31. Throughout this period, multimodal phenotyping and advanced diagnostics provided invaluable insights into the pathophysiology of xenograft rejection. Notably, donor-derived cell-free DNA (cfDNA) emerged as a sensitive biomarker for early graft injury, underscoring its potential utility in future xenotransplantation monitoring.

Histological examination at autopsy revealed widespread endothelial damage, secondary myocyte ischemia, and progressive fibrosis within the xenograft. These findings, consistent with AMR, underscored the need for enhanced immunosuppressive strategies and further genetic modifications to improve graft resilience. Additionally, the autopsy highlighted the challenges of size mismatches and the potential impact of graft oversizing on functional outcomes.

This second case of porcine-to-human heart transplantation has provided critical insights into the complexities of xenotransplantation. The lessons learned emphasize the importance of precise immunological control, early detection of rejection, and the integration of multimodal diagnostic tools. While the graft ultimately failed after 40 days, the procedure demonstrated the feasibility of porcine heart transplantation as a bridge to life for patients with no other therapeutic options. The patient’s willingness to participate in this experimental endeavor reflects the profound hope that xenotransplantation holds for addressing the global organ shortage.

Future advancements in the field will focus on addressing key challenges identified in this case. Enhancing the genetic engineering of donor animals to include additional complement regulatory proteins, such as CD59, may mitigate the risk of AMR. Optimizing immunosuppressive protocols to achieve therapeutic drug levels earlier in the postoperative course will be crucial. Additionally, developing strategies to reduce the need for blood product transfusions and minimize the risk of passive antibody transfer will enhance patient safety.

This landmark case represents a pivotal step toward the realization of xenotransplantation as a viable clinical therapy. The knowledge gained will inform ongoing research and guide the development of more robust and reliable solutions to extend the survival and improve the quality of life for future recipients. As the field continues to evolve, collaboration among researchers, clinicians, and regulatory bodies will be essential to achieving the full potential of xenotransplantation in transforming organ transplantation and addressing the pressing global demand for donor organs.

Subject of Research: Transplantation of genetically modified porcine hearts into human recipients.
Article Title: Transplantation of a Genetically Modified Porcine Heart into a Live Human
News Publication Date: 08 January 2025
Article Doi References: 10.1038/s41591-025-00123-x
Image Credits: Not provided
Keywords: Xenotransplantation, Porcine Heart Transplant, Genetically Modified Organ, Antibody-Mediated Rejection, Cardiac Failure, Organ Shortage, Immunosuppression, Biopreservation, Donor Screening, Biomedical Innovation

Brain maturation, a cornerstone of human development, shows distinct sex-related patterns that begin as early as infancy. Girls, compared to boys, exhibit advanced inter-hemispheric fiber development and higher cortical function maturation rates, which may explain differences in sleep physiology and duration. For example, studies have demonstrated that girls experience more defined states during wakefulness and sleep and have a higher prevalence of slow-wave activity (SWA) during sleep. This phenomenon reflects deeper sleep and potentially greater cortical plasticity, particularly in areas governing language functions. Boys, conversely, display heightened SWA in the right prefrontal cortex, a region linked to spatial abilities. These distinctions hint at a broader interplay between brain structure and sex-specific cognitive functions.

Sleep duration and quality also exhibit consistent sex differences. From infancy through adolescence, girls tend to sleep longer with less fragmentation compared to boys. Large-scale studies have confirmed that these differences manifest early, persist across developmental stages, and may stem from biological factors. Girls typically have a lower sleep latency and better sleep efficiency, with a notable need to compensate for sleep deficits during weekends, particularly in adolescence. Puberty amplifies these differences, with girls experiencing earlier declines in SWA and shifts in circadian rhythms. These changes are linked to hormonal influences, particularly oestradiol, which shapes brain circuits and sleep-wake systems from fetal stages onward.

Adolescence brings additional complexities, as girls report higher rates of insomnia symptoms compared to boys. This divergence, observed as early as Tanner stage four of puberty, is influenced by stress reactivity, emotional processing, and fluctuating ovarian hormone levels. Girls are also more likely to experience objective sleep disturbances, such as difficulty initiating and maintaining sleep, as puberty progresses. These challenges may be exacerbated by social and environmental stressors, creating a feedback loop that reinforces sleep difficulties.

Sleep disorders, including insomnia, show clear sex-related prevalence patterns. Boys are at greater risk in early childhood, while girls surpass boys in adolescence, with a sharp rise in insomnia symptoms. Recent studies highlight that boys are more prone to non-rapid eye movement (NREM) parasomnias in childhood, whereas adolescent girls are more susceptible to insomnia, which is often linked to stress and hormonal fluctuations. This shift underscores the interplay between biological and psychosocial factors in shaping sleep health.

Hormonal influences play a pivotal role in these differences. Oestradiol, a key female sex hormone, impacts sleep architecture by promoting sleep stability and influencing the brain regions associated with sleep regulation. These effects begin in fetal development and persist through puberty, explaining why girls typically experience more restorative sleep than boys. Conversely, testosterone appears to have a negligible impact on sleep patterns, highlighting the unique influence of female sex steroids.

Biological sex and sleep physiology are intertwined from the earliest stages of life. Neonatal studies reveal that girls exhibit more consolidated sleep patterns, while boys display greater variability in sleep states. These differences are mirrored in brain imaging studies, where girls show advanced cortical maturation linked to language and emotional processing. Such findings suggest that sleep is not merely a passive state but an active process deeply connected to brain development and function.

As children transition into adolescence, sleep duration declines, and circadian rhythms shift. Girls typically experience these changes earlier than boys, likely due to the earlier onset of puberty. This period is marked by significant hormonal changes, including fluctuations in oestradiol and other sex steroids, which further influence sleep patterns. The delayed timing of sleep, a hallmark of adolescence, is more pronounced in boys, who tend to exhibit later chronotypes. However, girls often report greater difficulty adapting to these changes, leading to increased sleep debt and a heightened risk of insomnia.

The psychosocial context cannot be ignored when examining these differences. Adolescent girls face unique stressors, including academic pressures, social expectations, and emotional challenges, all of which can disrupt sleep. Studies have shown that girls are more reactive to stress and more likely to experience mood disorders, both of which are closely linked to sleep disturbances. Boys, while less likely to report insomnia, are not immune to these challenges, particularly as societal expectations around masculinity often discourage them from seeking help for emotional or psychological issues.

Cognitive development also intersects with sleep in gender-specific ways. Girls tend to outperform boys in language-related tasks, a distinction that may be linked to their higher levels of SWA in cortical regions associated with language processing. Boys, on the other hand, excel in spatial tasks, reflecting the different areas of the brain activated during sleep. These differences highlight the role of sleep in reinforcing cognitive strengths and suggest that optimizing sleep health could have far-reaching implications for academic and personal success.

Addressing sleep disparities requires a multifaceted approach. Schools, families, and healthcare providers must work together to create environments that support healthy sleep habits. This includes promoting consistent sleep schedules, reducing screen time before bed, and addressing the unique stressors faced by boys and girls. For adolescents, interventions should be tailored to their developmental stage, taking into account the hormonal and psychosocial factors that influence sleep.

Future research should focus on the mechanisms underlying these differences, particularly the role of sex hormones and their interaction with environmental factors. Longitudinal studies tracking sleep patterns from infancy to adulthood could provide valuable insights into how these differences evolve and how they can be addressed. Additionally, exploring the impact of sleep interventions on cognitive and emotional outcomes could inform more effective strategies for improving sleep health.

In conclusion, the interplay between sex, brain maturation, and sleep is a complex but critical area of study. From infancy through adulthood, girls consistently exhibit longer, higher-quality sleep than boys, a difference rooted in both biology and environment. These patterns have profound implications for cognitive development, emotional well-being, and overall health. By recognizing and addressing these differences, we can promote better sleep health and improve the quality of life for individuals across all stages of development.

Subject of Research: Sex and gender differences in sleep during development.
Article Title: Sleep during development: Sex and gender differences.
Article DOI References: https://doi.org/10.1016/j.smrv.2020.101276
Image Credits: Not specified.
Keywords: Sleep, Sex-specific, Gender, Maturation, Infant, Children, Adolescents.

Lead researcher, Associate Professor Mikaël Martino, from Monash University’s Australian Regenerative Medicine Institute (ARMI) in Melbourne, Australia, said the discovery “could transform regenerative medicine, because it sheds light on the crucial role of sensory neurons in orchestrating the repair and regeneration of tissues, offering promising implications for improving patient outcomes.”

The cost of managing poorly healing wounds costs around $250 billion a year. “In adults with diabetes alone – where poor blood flow can lead to quickly worsening wounds that are often very slow or impossible to heal – the lifetime risk of developing a diabetic foot ulcer (DFU), the most common diabetes-related wound, is 20 to 35 per cent and this number is rising with increased longevity and medical complexity of people with diabetes,” co-lead author, ARMI’s Dr Yen-Zhen Lu said.

Nociceptive sensory neurons, also called nociceptors, are the nerves in our body that sense pain. These neurons alert us to potentially damaging stimuli in tissues by detecting dangers like tissue damage, inflammation, extremes in temperature, and pressure.

The researchers discovered that – during the healing process – sensory neuron endings grow into injured skin and muscle tissues, communicating with immune cells through a neuropeptide called calcitonin gene-related peptide (CGRP).

“Remarkably, this neuropeptide acts on immune cells to control them, facilitating tissue healing after injury,” Associate Professor Martino said.

Importantly they found that sensory neurons are crucial to the dissemination of CGRP because they showed that the selective removal of sensory neurons in mice reduce CGRP and significantly impairs skin wound healing and muscle regeneration following injury.

When the scientists administered an engineered version of CGRP to mice with neuropathy similar to that seen in diabetic patients, it led to rapid wound healing and muscle regeneration.

According to Associate Professor Martino, these findings hold significant promise for regenerative medicine, particularly for the treatment of poorly-healing tissues and chronic wounds.

“By harnessing neuro-immune interactions, the team aims to develop innovative therapies that address one of the root causes of impaired tissue healing, offering hope to millions,” he said.

“This study has uncovered significant implications for advancing our understanding of the tissue healing process after acute injury. Harnessing the potential of this neuro-immuno-regenerative axis opens new avenues for effective therapies, whether as standalone treatments or in combination with existing therapeutic approaches. “

The new grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases will also support a second case control study, building upon earlier TEDDY analyses examining how genetic factors and environmental exposures such as infectious agents, diet, and psychosocial stress affect T1D development in high-risk children. The extended project will incorporate viral biomarkers to help explain how viruses may trigger or contribute to the disease process.

Distinguished University Health Professor Jeffrey Krischer, PhD, director of the Health Informatics Institute at the USF Health Morsani College of Medicine, is the principal investigator for TEDDY. He has overseen the NIH-supported data coordinating center for this consortium since its inception in 2004. The Health Informatics Institute employs advanced technologies such as proteomics, epigenetics, gene expression analyses, and metabolomics for TEDDY and other NIH initiatives. Under Dr. Krischer’s leadership, USF has built an internationally recognized hub for epidemiological research in T1D.

A 2019 Nature Medicine paper by USF Health’s Kendra Vehik, PhD, and colleagues, reporting on unexpected connections between viruses and autoimmune-related diabetes, was recently highlighted by Nature as one of 24 milestones in diabetes research over the last 100 years (milestone No. 23).

Type 1 diabetes is an autoimmune disease in which the body’s immune system attacks the pancreatic β-cells making insulin – a process that occurs over months or many years. The presence of autoantibodies (immune proteins) in circulating blood indicates that the body has begun targeting its own tissues or organs.

TEDDY researchers at six clinical centers in the U.S. and Europe have been following 8,500 children from birth up to age 15, with the aim of identifying environmental factors that influence autoimmune destruction of β-cells. Beta cell autoimmunity ultimately leads to the onset of T1D, which requires life-long insulin injections to treat symptoms.

“Our TEDDY study group has made great strides in understanding the different biological pathways by which a child may develop diabetes-related autoimmunity,” Dr. Krischer said. “We are grateful to the many patients and families who collaborate in our studies. Their resolve inspires us to accelerate our efforts to pinpoint the mechanisms of type 1 diabetes, with the goal of preventing, delaying or reversing this life-altering condition.”

The exact causes of TD1 are unknown. But TEDDY has more clearly defined combined risk factors that can help predict β-cell autoimmunity and T1D onset, including the rates of disease progression, and the distinct stages of type 1 diabetes development.

“Dr. Krischer and his team have provided valuable insights into the interplay between genetic and environmental factors underlying the complex disease process of autoimmune diabetes,” said Charles J. Lockwood, MD, senior vice president of USF Health and dean of the Morsani College of Medicine. “Their work, powered by a research platform supporting high-performance computing and big data, is rigorous and critically important for finding new treatments and preventive approaches.”

Key discoveries from TEDDY investigations over the last several years include:

– Maternal stress during pregnancy and child’s T1D genetic risk: Certain psychological stress during pregnancy (interpersonal and job-related life events) are differentially related to first-appearing autoantibodies -insulin autoantibodies (IAA) vs. glutamic acid decarboxylase autoantibodies (GADA). Excess T1D risk often depends upon specific interactions between the mother’s environmental stress and the child’s genes.

– Distinct autoantibody spreading and progression to disease: Detailed information about the order, timing and type of autoantibodies appearing after the first autoantibody can significantly improve prediction of which children are most likely to advance from initial autoimmunity to symptomatic T1D more rapidly.

– A possible infectious cause of diabetes: In young children at increased genetic risk for T1D, prolonged enterovirus infection plays a role in the development of autoimmunity that precedes T1D diagnosis. This work was recently highlighted

– Human gut microbiome in early-onset T1D: For the first time, TEDDY extensively characterized the developing gut microbiome (collection of bacteria, viruses and other microorganisms inhabiting the gastrointestinal tract) in relation to T1D. The work laid the foundation to identify gut microbes that may predict, protect against. or cause T1D risk or disease progression.

– Gene-environment interactions modify risk of diabetes-related autoimmunity: In TEDDY children up to age 6, T1D-related immunological changes were clearly dependent upon the interactions of genetic factors and environmental exposures that give rise to IAA or GADA as the first-appearing autoantibodies.

– Linking early supplemental probiotics with T1D autoimmunity: Early intake of probiotics, potentially helpful in maintaining the balance of gut microbes, may decrease the risk of autoimmunity in children at highest genetic risk for T1D. Further studies are needed before probiotic supplementation could be recommended.

The new grant is funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH under Award Number U01DK128847.

###

USF Health’s mission is to envision and implement the future of health. It is the partnership of the USF Health Morsani College of Medicine, the College of Nursing, the College of Public Health, the Taneja College of Pharmacy, the School of Physical Therapy and Rehabilitation Sciences, the Biomedical Sciences Graduate and Postdoctoral Programs, and USF Health’s multispecialty physicians group. The University of South Florida is a high-impact global research university dedicated to student success. Over the past 10 years, no other public university in the country has risen faster in U.S. News & World Report’s national university rankings than USF. For more information, visit health.usf.edu

In higher organisms, cells and organelles are surrounded by a membrane, which plays a crucial role in not just creating a barrier from the external environment but also mediating exchange of fluids, electrolytes, proteins, and other useful material. Usually, these membranes are composed of water-repelling layers formed by lipid molecules, with various “transmembrane” proteins embedded in this double-layered sheet. These proteins are assembled in a way such that they create unique “gates” or “channels” that open and close in response to selective molecules or ions under specific conditions. These properties of “selectivity” and “sensing capacity” of a biological membrane come from its sophisticated structure, and together they make these membranes an attractive model for the synthesis of novel materials used to develop advanced sensing and separation devices. However, artificially developing such molecular assemblies―that can assemble itself in a membrane in a functionally active orientation―has remained challenging until now.

Advancing the research on artificial molecules, in a study published in Nature Communications別窓 , scientists from Tokyo Tech developed a synthetic channel that can mimic the ion-transporting activity of natural ion channels. Prof Kazushi Kinbara and Prof Takahiro Muraoka, the co-authors of the study, explain, “A major obstacle that limits the application of artificial transmembrane molecules is achieving the functionally active orientation. We tried to create a transmembrane molecule that would overcome this difficulty.”

To achieve this goal, the scientists focused on the structure of a biological ion channel that spans the membrane multiple times, and used it as the basis to design two artificial molecules. These molecules were composed of both water-repelling structural blocks, called BPO unit, and water-soluble parts called oligoethylene glycol chains. These structural features lend these artificial molecules the capacity to self-aggregate when embedded in membranes. The molecules also contained phosphate groups that further helped them to achieve the correct orientation across the membranes.

Next, the scientists focused on one of the two molecules, to analyze its structural properties. They observed that when suitable bait-like “ligand” molecules were added to a solution containing the artificial molecule, they successfully bound to the structure―confirming that the structure was indeed functionally active. Moreover, when these molecules were introduced to a preformed membrane, they could insert and orient themselves in the membrane on their own. In the presence of the specific ligands, the membrane-embedded macromolecules changed their structures and transported ions, including lithium, potassium, and sodium ions. Because the synthetic molecule showed promising results with artificial membranes, the scientists then tested it in living cells. Using a technique called fluorescence microscopy, they observed that the macromolecule showed the same functional properties, including differential ligand binding and regulated ion transport activities, in biological membranes too!

Taken together, the study shows how an artificially designed molecule can self-assemble, localize, orient, and mimic the biological ion transport process. These findings can potentially spur advances in the field of biomimetic regulation. The authors optimistically conclude, “The promising results of our study addressed a persistent limitation that blocked the way of using artificial biomimetic membrane proteins in applied fields.”